Clinical data | |
---|---|
Trade names | Marcoumar, Marcumar, Falithrom |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a699003 |
Pregnancy category | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 100%[1] |
Protein binding | 99% |
Metabolism | Liver (CYP2C9, CYP3A4) |
Metabolites | Hydroxyl derivatives, glucuronides |
Elimination half-life | 6–7 days |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.464 |
Chemical and physical data | |
Formula | C18H16O3 |
Molar mass | 280.323 g·mol−1 |
3D model (JSmol) | |
Melting point | 177–181 °C (351–358 °F) |
| |
| |
(verify) |
Phenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is a long-acting anticoagulant to be taken by mouth, and a coumarin derivative.[2] It acts as a vitamin K antagonist and inhibits blood clotting (coagulation) by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders such as heart attacks and pulmonary (lung) embolism. The most common adverse effect is bleeding. The drug interacts with a large number of other medications, including aspirin and St John's Wort. It is the standard coumarin used in Germany,[3] Austria,[4] and other European countries.[5]
Arzneistoff-Profile
was invoked but never defined (see the help page).AC
was invoked but never defined (see the help page).